<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <committeeReports />
    <updateDate>2018-08-28T20:05:33Z</updateDate>
    <laws />
    <billType>HR</billType>
    <subjects>
      <billSubjects>
        <policyArea>
          <name>Health</name>
        </policyArea>
        <legislativeSubjects>
          <item>
            <name>Administrative law and regulatory procedures</name>
          </item>
          <item>
            <name>Department of Health and Human Services</name>
          </item>
          <item>
            <name>Drug safety, medical device, and laboratory regulation</name>
          </item>
          <item>
            <name>Drug, alcohol, tobacco use</name>
          </item>
        </legislativeSubjects>
      </billSubjects>
    </subjects>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <recordedVotes />
    <originChamber>House</originChamber>
    <latestAction>
      <text>Referred to the Subcommittee on Health.</text>
      <links />
      <actionDate>2017-04-07</actionDate>
    </latestAction>
    <constitutionalAuthorityStatementText><![CDATA[<pre>[Congressional Record Volume 163, Number 60 (Thursday, April 6, 2017)]From the Congressional Record Online through the Government Publishing Office [<a href='http://www.gpo.gov'>www.gpo.gov</a>]By Mr. GRIFFITH:H.R. 2025.Congress has the power to enact this legislation pursuantto the following:This bill is enacted pursuant to the power granted toCongress under Article I, Section 8 of the United StatesConstitution.[Page H2791]</pre>]]></constitutionalAuthorityStatementText>
    <billNumber>2025</billNumber>
    <committees>
      <billCommittees>
        <item>
          <systemCode>hsif00</systemCode>
          <subcommittees>
            <item>
              <activities>
                <item>
                  <name>Referred to</name>
                  <date>2017-04-07T14:49:07Z</date>
                </item>
              </activities>
              <name>Health Subcommittee</name>
              <systemCode>hsif14</systemCode>
            </item>
          </subcommittees>
          <activities>
            <item>
              <name>Referred to</name>
              <date>2017-04-06T13:14:50Z</date>
            </item>
          </activities>
          <name>Energy and Commerce Committee</name>
          <chamber>House</chamber>
          <type>Standing</type>
        </item>
      </billCommittees>
    </committees>
    <introducedDate>2017-04-06</introducedDate>
    <cosponsors>
      <item>
        <bioguideId>C001106</bioguideId>
        <party>R</party>
        <firstName>Ryan</firstName>
        <state>PA</state>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <middleName>A.</middleName>
        <identifiers>
          <bioguideId>C001106</bioguideId>
          <lisID>2266</lisID>
          <gpoId />
        </identifiers>
        <fullName>Rep. Costello, Ryan A. [R-PA-6]</fullName>
        <district>6</district>
        <lastName>Costello</lastName>
        <sponsorshipDate>2017-04-06</sponsorshipDate>
        <sponsorshipWithdrawnDate />
      </item>
    </cosponsors>
    <notes />
    <relatedBills />
    <title>Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017</title>
    <sponsors>
      <item>
        <district>9</district>
        <fullName>Rep. Griffith, H. Morgan [R-VA-9]</fullName>
        <firstName>H.</firstName>
        <lastName>Griffith</lastName>
        <state>VA</state>
        <bioguideId>G000568</bioguideId>
        <party>R</party>
        <identifiers>
          <lisID>2070</lisID>
          <bioguideId>G000568</bioguideId>
          <gpoId>8200</gpoId>
        </identifiers>
        <byRequestType />
        <middleName>Morgan</middleName>
      </item>
    </sponsors>
    <congress>115</congress>
    <version>1.0.0</version>
    <amendments />
    <titles>
      <item>
        <titleType>Short Titles as Introduced</titleType>
        <title>Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017</title>
        <parentTitleType />
        <chamberCode />
        <chamberName />
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <title>To amend section 505(c)(3)(E) of the Federal Food, Drug, and Cosmetic Act to prevent certain applications from being considered ineligible for approval under section 505(c) of such Act on the basis that the proposed labeling includes information describing abuse-deterrent properties that otherwise would be blocked by exclusivity under clause (iii) or (iv) of section 503(c)(3)(E) of such Act, and for other purposes.</title>
        <parentTitleType />
        <chamberCode />
        <chamberName />
      </item>
      <item>
        <titleType>Display Title</titleType>
        <title>Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017</title>
        <parentTitleType />
        <chamberCode />
        <chamberName />
      </item>
      <item>
        <titleType>(Extracted from GPO) Short Titles as Introduced</titleType>
        <title>Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017</title>
        <parentTitleType />
        <chamberCode />
        <chamberName />
      </item>
    </titles>
    <createDate>2017-04-07T03:11:59Z</createDate>
    <cboCostEstimates />
    <calendarNumbers />
    <actions>
      <actionTypeCounts>
        <introducedInHouse>1</introducedInHouse>
        <introducedInTheHouse>1</introducedInTheHouse>
        <billReferrals>1</billReferrals>
        <placeholderTextForH>1</placeholderTextForH>
      </actionTypeCounts>
      <item>
        <actionDate>2017-04-07</actionDate>
        <committee>
          <systemCode>hsif14</systemCode>
          <name>Health Subcommittee</name>
        </committee>
        <links />
        <sourceSystem>
          <name>House committee actions</name>
          <code>1</code>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2017-04-06</actionDate>
        <links />
        <text>Referred to the House Committee on Energy and Commerce.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
        <committee>
          <systemCode>hsif00</systemCode>
          <name>Energy and Commerce Committee</name>
        </committee>
      </item>
      <item>
        <actionDate>2017-04-06</actionDate>
        <links />
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
        <committee />
      </item>
      <item>
        <actionDate>2017-04-06</actionDate>
        <links />
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
        <committee />
      </item>
      <actionByCounts>
        <houseOfRepresentatives>4</houseOfRepresentatives>
      </actionByCounts>
    </actions>
    <summaries>
      <billSummaries>
        <item>
          <updateDate>2017-04-06T04:00:00Z</updateDate>
          <lastSummaryUpdateDate>2018-08-10T15:04:45Z</lastSummaryUpdateDate>
          <text><![CDATA[<p><b>Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017</b></p> <p>This bill amends the Federal Food, Drug, and Cosmetic Act to prevent an application for a new drug from being considered ineligible for approval because its labeling includes information describing abuse-deterrent properties that otherwise would be blocked by market exclusivity provisions. </p> <p>The Department of Health and Human Services shall issue draft guidance and publish final guidance regarding the award and scope of exclusivity for new drugs with properties designed to deter abuse and the exceptions to such exclusivity.</p> <p>The bill applies to applications and supplements to applications that are submitted or pending approval on or after January 1, 2017.</p>]]></text>
          <actionDate>2017-04-06</actionDate>
          <actionDesc>Introduced in House</actionDesc>
          <name>Introduced in House</name>
          <versionCode>00</versionCode>
        </item>
      </billSummaries>
    </summaries>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

